FIELD: medicine.
SUBSTANCE: method includes intramuscular administration of a suspension of autologous peripheral blood stem cells (PBSC) into several points of the muscle mass in the ischemic zone. Three to four days after PBSC administration, vascular endothelial growth factor (VEGF) is introduced into the same muscular mass, depth, place of injection in the muscle mass and the fact of PBSC and VEGF spread is determined and fixed by ultrasound control.
EFFECT: use of the invention makes it possible to reduce the number of complications with introduction of peripheral blood stem cells.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF ISCHEMIC ANGIOPATHY OF LOWER EXTREMITY VESSELS | 2017 |
|
RU2649498C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC LOWER LIMB ISCHEMIA | 2021 |
|
RU2759478C1 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC LOWER EXTREMITY ISCHEMIA CASES | 2005 |
|
RU2286159C1 |
| METHOD OF COMBINED SURGICAL STIMULATION OF LOWER EXTREMITY CHRONIC LOWER LIMB NEOANGIOGENESIS | 2018 |
|
RU2703395C1 |
| METHOD FOR TREATING DIABETIC FOOT SYNDROME BEFORE FORMATION OF ULCEROUS DEFECT USING EXTRACORPORAL SHOCK WAVE THERAPY | 2016 |
|
RU2632683C1 |
| METHOD FOR SURGICAL MANAGEMENT OF CHRONIC LOWER LIMB ISCHEMIA CAUSED BY DISTAL VASCULAR INVOLVEMENT | 2013 |
|
RU2529410C1 |
| AGENT FOR TREATMENT OF ISCHEMIC LESIONS OF TISSUES AND METHOD OF ITS USE | 2012 |
|
RU2522778C2 |
| METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIA THREATENING LIMB LOSS | 2021 |
|
RU2780605C1 |
| METHOD OF TREATING LOWER EXTREMITY ISCHEMIA | 2012 |
|
RU2546007C2 |
| METHOD FOR STIMULATING ANGIOGENESIS USING GENETICALLY MODIFIED UMBILICAL CORD BLOOD CELLS | 2017 |
|
RU2663470C2 |
